Navigation
The Company
Our Science
mTOR Pathway
nab
Technology Platform
Publications and Abstracts
Our Medicine
Our Medicine
Advanced Malignant PEComa
Pipeline
Patients
Overview
Patient Advocacy
Contact Us
General Contact
For Healthcare Professionals
Careers
Archive: April 20, 2018
Home
2018
April
20
20
Apr
2018
Antitumor activity of ABI-009 (
nab
-rapamycin) in combination with anti-PD1 antibody in a syngeneic mouse model of B16 melanoma
0
0
April 20, 2018
April 20, 2018